Modulation of hu/mu severe combined immunodeficient (SCID) mouse arthritis by local application of human recombinant IL-1β, IL-2 and IL-6

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 96-102

  Kuhn, H ^a,b   Ermann, J ^a   Sack, U ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b UNIVERSITY HOSPITAL LEIPZIG   (Germany)

Author keywords

Animal model; Arthritis; Inflammation; Interleukin; SCID mouse

Indexed keywords

INTERLEUKIN 6; RECOMBINANT INTERLEUKIN 1BETA; RECOMBINANT INTERLEUKIN 2; RECOMBINANT INTERLEUKIN 6;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CLINICAL ARTICLE; COMBINED IMMUNODEFICIENCY; CONTROLLED STUDY; HUMAN; IMMUNOHISTOCHEMISTRY; MOUSE; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SYNOVIUM; TOPICAL DRUG ADMINISTRATION; XENOGRAFT;

EID: 0031016416     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-883.x     Document Type: Article

References (50)

1. Sack U, Kuhn H, Ermann J, Kinne RW, Vogt S, Jungmichel D, Emmrich F. Synovia tissue implants from patients with rheumatoid arthritis cause cartilage destruction in knee joints of scid.bg mice. J Rheumatol 1994; 21:10-16.
2. Bosnia GC, Custer RP, Bosnia MJ. A severe combined immunodeficiency mutation in the mouse. Nature 1983; 301:527-30.
3. Bosma MJ. The scid mutation: occurence and effect. Curr Top Microbiol Immunol 1989; 152:3-9.
4. Sack U, Kuhn H, Kämpfer I, Genest M, Arnold S, Pfeiffer G, Emmrich F. Orthotopic implantation of inflamed synovial tissue from RA-patients induces a characteristic arthritis in immunodeficient (SCID) mice. J Autoimmun 1996; 9:51-58.
5. Kuhn H, Sack U, Ermann J, Emmrich F. Aggravation of articular destruction in the human/murine SCID arthritis by local application of human interleukin-1 and interleukin-2. Immunobiology 1993; 189:120.
6. Kuhn H, Sack U, Ermann J, Emmrich F. IL-1β and IL-2, but not IL-6 support the inflammatory reaction in the human/murine SCID arthritis. Z Rheumatol 1994; 53:19.
7. Miossec P, Dinarello CA, Ziff M. Interleukin-1 lymphocyte chemotactic activity in rheumatoid arthritis synovial fluid. Arthritis Rheum 1986; 29:461-9.
8. Goldring MB, Birkhead J, Sandell LJ, Kimtira T, Krane SM. Interleukin 1 suppresses expression of cartilage-specific types II and IX and increases type I and III collagens in human chondrocytes. J Clin Invest 1988; 82:2026-37.
9. Pettipher ER, Higgs GA, Henderson B. Interleukin 1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986; 83:8749-53.
10. Arner EC, Pratta MA. Independent effects of interleukin-1 on proteoglycan breakdown, proteoglycansynthesis and prostaglandin E2 release from cartilage in organ culture. Arthritis Rheum 1989; 32:288-97.
11. Saklatvala J. Der Beitrag von Zytokinen zur Gelenkzerstörung. In: Mohr W, Emmert KH, eds. Gelenkzerstörung bei entzündlichen rheumatischen Erkrankungen. Darmstadt: Steinkopff Verlag. 1989:75-82.
12. Hasty KA, Reife RA, Kang AH, Stuart JM. The role of stromelysin in the cartilage destruction that accompanies inflammatory arthritis. Arthritis Rheum 1990; 33:388-97.
13. Okada Y, Nagase H, Harris ED Jr. A metalloproteinase from human rheumatoid synovial fibroblasts that digests connective tissue matrix components. J Biol Chem 1986; 261:14245-55.
14. Richardson HJ, Elford PR, Sharrard RM, Meats JE, Russel RGG. Modulation of connective tissue metabolism by partially purified human interleukm 1. Cell Immunol 1985; 90:41-51.
15. Bunning RAD, Crawford A, Richardson HJ, Opdenakker G, van Damme J, Russell RGG. Interleukin 1 preferentially stimulates the production of tissue-type plasminogen activator by human articular chondrocytes. Biochem Biophys Acta 1986; 924:473-82.
16. Smith KA. T-cell growth factor. Immunol Rev 1980; 51:337-57.
17. Waldmann TA. The structure, function and expression of interleukin-2 receptor on normal and malignant lymphocytes. Science 1986; 232:727-32.
18. Panayi GS, Lanchbury JS, Kingsley GH. The importance of the T cell in initiating and maintaining the chronic synovitis of rheumatoid arthritis. Arthritis Rheum 1992; 35:729-35.
19. Hirano T, Matsuda T, Turner M et al. Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol 1988; 18:1797-801.
20. Swaak AJ, van Rooyen A, Nieuwenhuis E, Aarden LA. Interleukin6 (IL-6) in synovial fluid and serum of patient with rheumatic diseases. Scand J Rheumatol 1988; 17:469-74.
21. Arnett FC, Edworthy SM, Bloch DA et al The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31:315-24.
22. Klareskog L. What can we learn about rheumatoid arthritis from animal models? Springer Semin Immunopathol 1989; 11:315-33.
23. Vladutiu AO. Can autoimmune diseases be induced in severe combined immunodeficient (SCID) mice? Res Immunol 1994; 145:363-70.
24. Rendt KE, Barry TS, Jones DM, Richter CB, McCachren SS, Haynes BF. Engraftment of human synoviuni into severe combined immune deficient mice. Migration of human peripheral blood T cells to engrafted human synovium and to mouse lymph nodes. J Immunol 1993; 151:7324-36.
25. Geiler T, Kriegsmann J, Keyszer GM, Gay RE, Gay S. A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 1994; 37:1664-71.
26. Hopkins SJ, Humphreys M, Jayson MIV. Cytokines in synovial fluid. I. The presence of biologically active and immunoreactive IL-1. Clin Exp Immunol 1988; 72:422-7.
27. Di Giovine FS, Poole S, Situnayake RD, Wadhwa M, Duff GW. Absence of correlation between indices of systemic inflammation and synovial fluid interleukin 1 (alpha and beta) in rheumatic diseases. Rheumatol Int 1990; 9:259-64.
28. Killar LM, Dunn CJ. Interleukin-1 potentiates the development of collagen-induced arthritis in mice. Clin Sci 1989; 76:535-8.
29. Nadal D, Albini B, Schlapfer E, Bernstein JM, Ogra PL. Role of Epstein Barr virus and interleukin 6 in the development of lymphomas of human origin in SCID mice engrafted with human tonsillar mononuclear cells. J Gen Virol 1992; 73:113-21.
30. Westacott CI, Whicher JT, Barnes IC, Thompson D, Swan AJ, Dieppe PA. Synovial fluid concentration of live different cytokines in rheumatic diseases. Ann Rheum Dis 1990; 49:676-81.
31. Farrar JJ, Benjamin WR, Hilfiker ML, Farrar WL, Fuller-Farrar J. The biochemistry, biology, and role of interleukin-2 in the induction of cytotoxic T cell and antibody-forming B cell responses. Immunol Rev 1982; 63:129-66.
32. Kaul R, Sharma A, Lisse JR, Christadoss P. Human recombinant IL-2 augments immunoglobulin and induces rheumatoid factor production by rheumatoid arthritis lymphocytes engrafted into severe combined immunodeficient mice. Clin Immunol Immunopathol 1995; 74:271-82.
33. Al-Janadi M, Al-Balla S, Al-Dalaan A, Ratiuddin S. Cytokine profile in systemic lupus erythematosus, rheumatoid arthritis and other rheumatic diseases. J Clin Immunol 1993; 13:58-67.
34. Nouri AME, Panayi GS, Goodman SM, Waugh APW. Deficient IL-2 production by rheumatoid arthritis lymphocytes. XVIth Int Congr Rheumatology 1985; F181:140.
35. Silver RM, Redelman D, Zvaifler NJ. Studies of rheumatoid synovial fluid lymphocytes. II. A comparison of their behavior with blood mononuclear cells in autologous mixed lymphocyte reaction and response to TCGF. Clin Immunol Immunopathol 1983; 27:15-21.
36. Combe B, Pope RM, Fishbaeh M, Darnell B, Baron S, Talal N. Interleukin 2 in rheumatoid arthritis: production of and response to interleukin 2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol 1985; 59:520-8.
37. + T cell repertoire in hu-PBL-SCID chimeras. J Exp Med 1994; 180:1817-27.
38. Tary Lehmann M, Saxon A. Human mature T cells that are anergic in vivo prevail in SCID mice reconstituted with human peripheral blood. J Exp Med 1992; 175:503-16.
39. Miyasaka N, Sato K, Hashimoto J et al. Constitutive Produktion of interleukin 6/B cell stimulatory factor-2 from inflammatory synovium. Clin Immunol Immunopathol 1989; 52:238-47.
40. Hardy RR, Hayakawa K, Shimizu M, Yamasaki K, Kishimoto T. Rheumatoid factor secretion from human Leu-1 B cells. Science 1987; 236:81-83.
41. Dasgupta B, Corkill M, Kirkham B, Gibson T, Panayi G. Serial estimation of interleukin 6 as a measure of systemic disease in rheumatic arthritis. J Rheumatol 1992; 19:22-25.
42. Mangge H, Kenzian H, Gallistl S et al. Serum cytokines in juvenile rheumatoid arthritis. Arthritis Rheum 1995; 38:211-20.
43. Nietfeld JJ, Wilbrmk B, Helle M et al. Interleukin-1 induced interleukin-6 is required for the inhibition of preteoglycan synthesis by interleukin-1 in human articular cartilage. Arthritis Rheum 1990; 33:1695-701.
44. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC, Dinarello CA. Correlation and interaction in the production of interleukin 6 (IL-6), IL-1 and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 1990; 75:40-47.
45. Guerne PA, Carson DA, Lotz M. IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol 1990; 144:499-505.
46. Guerne PA, Villiger P, Lotz M. Unique synergy and interaction between IL-6 and TGF-beta in the regulation of chondrocyte function. Clin Rheumatol 1990; 9:527 (Abstr.).
47. Allard SA, Bayliss MT, Maini RN. The synovium cartilage junction of the normal human knee. Arthritis Rheum 1990; 33:1170-9.
48. Ulich TR, Yin S, Guo K, Yi ES, Remick D, del Castillo J. Intratracheal injection of endotoxin and cytokines. II. Interleukin 6 and transforming growth factor beta inhibit acute inflammation. Am J Pathol 1991; 138:1097-101.
49. Chen W, Havell EA, Gigliotti F, Harmsen AG. Interleukin-6 Produktion in a murine model of Pneumocystis carini pneumonia: relation to resistance and inflammatory response. Infect Immun 1993; 61:97-102.
50. Sack U, Kinne RW, Marx T, Heppt P, Bender S, Emmrich F. Interleukin-6 synovial fluid associated with chronic synovitis in rheumatoid arthritis. Rheumatol Int 1993; 13:45-51.